Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 65 years or older on the day of inclusion~Exclusion Criteria:~* Febrile illness (oral temperature ≥37.5°C) on the day of inclusion~* Thrombocytopenia or bleeding disorder contraindicating intramuscular vaccination~* Unstable chronic illness~* Congenital or acquired immunodeficiency,~* Any blood or blood-derived product in the past 3 months~* Current abuse of alcohol or drug addiction~* Any vaccination in the past 4 weeks or planned in the 4 weeks following study vaccination~* Any vaccination against influenza in the past 6 months~* Subjects who previously received a vaccination against influenza by intradermal route

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Inactivated Split-Virion Influenza Vaccine for Intradermal Route
- 2 (Type: ACTIVE_COMPARATOR): Inactivated adjuvanted Influenza Vaccine for Intramuscular Route

Based on this trial design, predict the completion outcome and termination type (if applicable).